Upgrade Your Browser
We no longer support this version of your browser.
We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.
Return to the course you were viewing
Please see updated information from the FDA
The FDA is raising concerns about increased mortality with Maxipime (cefepime).
Maxipime is a broad-spectrum IV cephalosporin used for sicker patients with nosocomial pneumonia and other resistant infections.
Pharmacist's Letter includes:
Already a subscriber? Log in
Volume pricing available. Get a quote